An Industry Perspective on CD3 Bispecifics Starting Doses & Efficacious Dose Projections

Time: 11:00 am
day: Pre-Conference Focus Day


• Strategies for selection of starting doses to balance patient safety and minimize patient’s exposure to subtherapeutic doses
• Approaches for predicting efficacious doses
• Challenges and opportunities for defining optimal biological doses for CD3 bispecifics